Altered Fos-like immunoreactivity in terminal regions of the mesotelencephalic dopamine system is associated with reappearance of tyrosine hydroxylase immunoreactivity at the sites of focal 6-hydroxydopamine lesions in the nucleus accumbens

Brain Research

Volumn 736, Issue 1-2, 1996, Pages 270-279

  Chapman, M A ^a   Zahm, D S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immediate early gene; immunohistochemistry; mesocortical; mesoprefrontal; reinnervation; ventral striatum

Indexed keywords

OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NERVE ENDING; NERVE REGENERATION; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

EID: 0030583657     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00714-7     Document Type: Article

References (40)

1. [1] Anden, N.E., Dahlstrom, A., Fuxe, K. and Larsson, K., Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon, Life Sci., 4 (1965) 1275-1279.
2. [2] Barber, J.R. and Verma, I.M., Modification of fos protein: phosphorylation of c-fos but not v-fos. Mol. Cell Biol., 7 (1987) 2201-2211.
3. [3] Brog, J.S., Salyapongse, Deutch, A.Y. and Zahm, D.S., The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum: immunohistochemical detection of retrogradely transported Fluoro-Gold, J. Camp. Neurol., 338 (1993) 225-278.
4. [4] Brog, J.S. and Zahm, D.S., Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration, Neuroscience, 65 (1995) 71-86.
5. [5] Choulli, K., Herman, J.P., Rivet, J.M., Simon, H. and LeMoal, M., Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat, Brain Res., 407 (1987) 376-380.
6. [6] Cole, D.G., Kobierski, L.A., Konradi, C. and Hyman, S.E., 6-hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element binding protein in striatal neurons, Proc. Natl Acad. Sci. USA, 91 (1994) 9631-9635.
7. [7] Cole, D.G., Dopaminergic activation of Fos and the rat model of Parkinson's Disease. In H. Narabayashi, T. Nagatsu, N. Yanagisawa and Y. Mizuno (Eds.), Parkinson's Disease: From Basic Research to Treatment, Advances in Neurology, Vol. 60, Raven Press, New York, 1993, pp. 334-337.
8. [8] Cooper, A.J., Wooler, S. and Mitchell, I.J., Elevated striatal Fos immunoreactivity following 6-hydroxydopamine lesioning of the rat is mediated by excitatory amino acid transmission, Neurosci. Lett., 194 (1995) 73-76.
9. [9] Cullinan, W.E., Herman, J.P., Battaglia, D.F., Akil, H. and Watson, S.J., Pattern and time course of immediate early gene expression in rat brain following actue stress, Neuroscience, 64 (1994) 477-505.
10. [10] Curran, T., Miller, A.D., Zokas, L. and Verma, I.M., Viral and cellular fos proteins: A comparative analysis, Cell, 36 (1984) 259-268.
11. [11] Deutch, A.Y., Lee, M.C., Gilham, M.H., Cameron, D.A., Goldstein, M. and Iadarola, M.J., Stress selectively increases Fos protein in dopamine neurons innervating the prefrontal cortex, Cereb. Cortex, 1 (1991), 273-292.
12. [12] Dragunow, M. and Faull, R., The use of c-fos as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods, 29 (1989) 261-265.
13. [13] Dragunow, M., Leah, J.D. and Faull, R.L.M., Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta, Mol. Brain Res., 10 (1991) 355-358.
14. [14] Dragunow, M. and Robertson, H.A., Brain injury induces c-fos protein(s) in nerve and glial-like cells in adult mammalian brain, Brain Res., 455 (1988) 295-299.
15. [15] Dragunow, M. and Robertson, H.A., Localization and induction of c-fos protein-like immunoreactive material in the nuclei of adult mammalian neurons, Brain Res., 440 (1988) 252-260.
16. [16] Fallon, J.H. and Moore, R.Y., Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum, J. Comp. Neurol., 180 (1978) 545-580.
17. [17] Gilad, G.M. and Reis, D.J., Collateral sprouting in central mesolimbic dopamine neurons: biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal fields and in cell bodies of A10 neurons. Brain Res., 160 (1979) 17-36.
18. [18] Heimer, L., Zahm, D.S., Churchill, L., Kalivas, P.W. and Wohltmann, C., Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience, 41 (1991) 89-125.
19. [19] Herdegen, T., Kovary, K., Buhl, A., Bravo, R., Zimmerman, M. and Gass, P., Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain, J. Comp. Neurol., 354 (1995) 39-56.
20. [20] Jacobs, O., Van Bree, L., Mailleux, P., Zhang, F., Schiffmann, S.N., Halleux, P., Albala, N. and Vanderhaeghen, J.J., Homolateral cerebrocortical increase of immediate early gene and neurotransmitter messenger RNAs after minimal cortical lesion: blockade by N-methyl-D-aspartate antagonist, Neuroscience, 59 (1994) 827-836.
21. [21] Jian, M., Staines, W.A., Iadarola, M.J. and Robertson, G.S., Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Mol. Brain Res., 19 (1993) 156-160.
22. [22] Katzman, R., Bjorklund, A., Owman, Ch., Stenevi, U. and West, K.A., Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions, Brain Res., 25 (1971) 579-596.
23. [23] Marcotte, E.R., Sullivan, R.M. and Mishra, R.K., Striatal G-proteins: effects of unilateral 6-hydroxydopamine lesions, Neurosci. Lett., 169 (1994) 195-198.
24. [24] McGeorge, A.J. and Faull, R.L.M., The organization of the projection from the cerebral cortex to the striatum in the rat, Neuroscience, 29 (1989) 503-537.
25. [25] Nakai, K., Niiyama, K., Kasamatsu, T., Naka, Y., Itakura, T. and Komai, N., Regeneration of norepinephrine-containing fibers in occipital cortex of adult cats, Brain Res. Bull., 35 (1994) 409-412.
26. [26] Nauta, W.J.H., Smith, G.P., Faull, R.L.M. and Domesick, V.B., Efferent connections and nigral afferents of the nucleus accumbens septi in the rat, Neuroscience, 3 (1978) 385-401.
27. [27] Paul, M.L., Graybiel, A.M., David, J.-C. and Robertson, H.A., D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's Disease, J. Neurosci., 12 (1992) 3729-3742.
28. [28] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
29. [29] Popovici, Th., Barbin, G. and Ben Ari, Y., Kainic acid-induced seizures increase c-fos-like protein in the hippocampus, Eur. J. Pharmacol., 150 (1988) 405-406.
30. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons, Neuroscience, 49 (1992) 285-296.
31. [31] Robinson, T.E. and Whishaw, I.Q., Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats, Brain Res., 450 (1988) 209-224.
32. [32] Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: Metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
33. [33] Sharp, F.R., Gonzalez, M.F., Hisanaga, K., Mobley, W.C. and Sagar, S.M., Induction of the c-fos gene product in rat forebrain following cortical lesions and NGF injections. Neurosci. Lett., 100 (1989) 117-122.
34. [34] Sharp, F.R., Sagar, S.M., Hicks, K., Lowenstein, D. and Hisanaga, K., c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress, J. Neurosci., 11 (1991) 2321-2331.
35. [35] Smeyne, R.J., Vendrell, M., Hayward, M., Baker, S.J., Miao, G.G., Schilling, K., Robertson, L.M., Curran, T. and Morgan, J.I., Continuous c-fos expression precedes programmed cell death in vivo, Nature, 363 (1993) 166-169.
36. [36] Snyder, G.L., Keller, R.W. and Zigmond, M.J., Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals, J. Pharmacol. Exp. Ther., 253 (1990) 867-876.
37. [37] Thierry, A.M., Tassin, J.P., Blanc, G. and Glowinski, J., Selective activation of the mesocortical DA system by stress. Nature, 263 (1976) 242-244.
38. [38] Vos, P.E., Steinbusch, H.W.M. and Van Ree, J.M., Reinnervation after destruction of the dopaminergic system in the rat nucleus accumbens: a quantitative immunohistochemical analysis, Neurosci. Lett., 207 (1996) 21-24.
39. [39] Walaas, I. and Fonnum, F., The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. Neuroscience, 4 (1979) 209-216.
40. [40] Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Stricker, E.M., Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci., 13 (1990) 290-296.